國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Phosphoinositides and disease

Falasca, Marco.

Phosphoinositides and disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Phosphoinositides and diseaseedited by Marco Falasca ; responsible series editor Peter K. Vogt.
其他作者:	Falasca, Marco.
出版者:	Dordrecht :Springer Netherlands :2012.
面頁冊數:	vi, 318 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Phosphoinositides.
電子資源:	http://dx.doi.org/10.1007/978-94-007-5025-8
ISBN:	9789400750258 (electronic bk.)

Phosphoinositides and disease
Phosphoinositides and disease[electronic resource] /edited by Marco Falasca ; responsible series editor Peter K. Vogt. - Dordrecht :Springer Netherlands :2012. - vi, 318 p. :ill., digital ;24 cm. - Current topics in microbiology and immunology,v.3620070-217X ;. - Current topics in microbiology and immunology ;v.351..

Phosphoinositides (PIs) are minor components of cellular membranes that play critical regulatory roles in several intracellular functions. This book describes the main enzymes regulating the turnover of each of the seven PIs in mammalian cells, some of their intracellular functions and some evidence of their involvement in human diseases. Due to the complex inter-relation between the distinct PIs and the plethora of functions that they can regulate inside a cell, this book is not meant to be a comprehensive coverage of all aspects of PIs signalling but rather an overview on the current state of the field and where it could go from here. Phosphoinositide and inositol phosphates interact with and modulate the recruitment and activation of key regulatory proteins and in doing so control diverse functions including cell growth and proliferation, apoptosis, cytoskeletal dynamics, insulin action, vesicle trafficking and nuclear function. Initially, inositide signaling was limited to the PLC pathway; however, it is now clear that all the seven phosphoinositides and more than 30 different inositol phosphates likely have specific signaling functions. Moreover there is a growing list of proteins that are regulated by inositol signaling. This has raised the question as to how inositol signaling can control diverse processes and yet maintain signaling specificity. Controlling the levels of inositol signaling molecules and their subcellular compartmentalisation is likely to be critical. This meeting will bring together scientists from different backgrounds to discuss how understanding inositol signaling may be used to target complex human diseases that manifest themselves when inositol signaling is deregulated.

ISBN: 9789400750258 (electronic bk.)Subjects--Topical Terms:

243660
Phosphoinositides.

Dewey Class. No.: 572.57

Phosphoinositides and disease
LDR:02619nmm a2200265 a 4500 001 353026
003 DE-He213
005 20121119144304.0
006 m d
007 cr nn 008maaau
008 121218s2012 ne s 0 eng d
020 $a 9789400750258 (electronic bk.)
020 $a 9789400750241 (paper)
035 $a 978-94-007-5025-8
040 $a GP $c GP
041 0 $a eng
082 0 4 $a 572.57 $2 23
090 $a QR1 $b .P575 2012
245 0 0 $a Phosphoinositides and disease $h [electronic resource] / $c edited by Marco Falasca ; responsible series editor Peter K. Vogt.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2012.
300 $a vi, 318 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current topics in microbiology and immunology, $x 0070-217X ; $v v.362
520 $a Phosphoinositides (PIs) are minor components of cellular membranes that play critical regulatory roles in several intracellular functions. This book describes the main enzymes regulating the turnover of each of the seven PIs in mammalian cells, some of their intracellular functions and some evidence of their involvement in human diseases. Due to the complex inter-relation between the distinct PIs and the plethora of functions that they can regulate inside a cell, this book is not meant to be a comprehensive coverage of all aspects of PIs signalling but rather an overview on the current state of the field and where it could go from here. Phosphoinositide and inositol phosphates interact with and modulate the recruitment and activation of key regulatory proteins and in doing so control diverse functions including cell growth and proliferation, apoptosis, cytoskeletal dynamics, insulin action, vesicle trafficking and nuclear function. Initially, inositide signaling was limited to the PLC pathway; however, it is now clear that all the seven phosphoinositides and more than 30 different inositol phosphates likely have specific signaling functions. Moreover there is a growing list of proteins that are regulated by inositol signaling. This has raised the question as to how inositol signaling can control diverse processes and yet maintain signaling specificity. Controlling the levels of inositol signaling molecules and their subcellular compartmentalisation is likely to be critical. This meeting will bring together scientists from different backgrounds to discuss how understanding inositol signaling may be used to target complex human diseases that manifest themselves when inositol signaling is deregulated.
650 0 $a Phosphoinositides. $3 243660
650 0 $a Phosphoinositides $x Pathophysiology. $3 585039
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Biomedicine general. $3 273948
700 1 $a Falasca, Marco. $3 585038
700 1 $a Vogt, Peter K. $3 275249
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Current topics in microbiology and immunology ; $v v.351. $3 557512
856 4 0 $u http://dx.doi.org/10.1007/978-94-007-5025-8
950 $a Biomedical and Life Sciences (Springer-11642)